Home > Income Statement > CORONA REMEDIES

CORONA REMEDIES
Revenue

    Back to Income Statement
CORONA REMEDIES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Net Sales ₹1,196 Cr₹10,145 Cr₹884 Cr₹884 Cr

What is the latest Revenue of CORONA REMEDIES ?

The latest Revenue ratio of CORONA REMEDIES is ₹1,196 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹1,196 Cr
Mar2025₹10,145 Cr
Mar2024₹884 Cr
Mar2023₹884 Cr

How is Revenue of CORONA REMEDIES Trending?

Years Revenue % Change
Mar2026 ₹1,196 Cr
-88.21
Mar2025 ₹10,145 Cr
1,047.53
Mar2024 ₹884 Cr
0.00
Mar2023 ₹884 Cr -

Compare Revenue of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,087.6 Cr -1.7% 13.7% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,982.0 Cr 0.9% 5.6% 14.1% Stock Analytics
DIVIS LABORATORIES ₹179,361.0 Cr 1.2% 3.7% -1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹164,737.0 Cr 4.4% 10.3% 42.1% Stock Analytics
CIPLA ₹115,655.0 Cr -1.7% 3.1% -4.2% Stock Analytics
DR REDDYS LABORATORIES ₹112,573.0 Cr 0.2% 5.7% 6% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-1.7%

13.7%

NA
SENSEX

-0.5%

3%

-8.5%


You may also like the below Video Courses